Abstract
Abstract A rapid, stability indicating high performance liquid chromatographic (HPLC) procedure for the determination of phenytoin prodrug (fosphenytoin) content in solutions, parenteral formulations and the active drug substance was developed. Reverse-phase liquid chromatography was performed using a 15 cm microparticulate (5 μm) NOVA-PAK phenyl packed column, a variable wavelength detector (214 nm), and a mobile phase that consisted of a buffer that was 0.025 M in potassium phosphate monobasic and 0.05 M in 1-heptanesulfonic acid sodium salt (pH = 4.1 with phosphoric acid) and methanol (65:35) pumped at 1.0 mL/minute. The method is precise and accurate, with three separate analysts achieving an accuracy greater than 99.0% and a relative standard deviation of less than 0.8%. A limit of detection determined by visual examination was found to be approximately 0.1 μg/mL. Accuracy of this method decreases at concentrations of less than 10 μg/mL fosphenytoin. Either peak height or peak area ratios at 214 nm c...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
